Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-164438
Filing Date
2025-07-24
Accepted
2025-07-24 16:30:47
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d949705ds3.htm S-3 344878
2 EX-5.1 d949705dex51.htm EX-5.1 8933
3 EX-23.1 d949705dex231.htm EX-23.1 2015
4 EX-FILING FEES d949705dexfilingfees.htm EX-FILING FEES 18445
5 GRAPHIC g949705dsp01.jpg GRAPHIC 3173
6 GRAPHIC g949705g18d41.jpg GRAPHIC 43748
7 GRAPHIC g949705g53d72.jpg GRAPHIC 47207
8 GRAPHIC g949705g56s75.jpg GRAPHIC 8719
  Complete submission text file 0001193125-25-164438.txt   513586
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288927 | Film No.: 251147400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)